Skip to main content

and
  1. Article

    Open Access

    Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant

    We report the levels of neutralising antibodies against Wuhan, Delta and Omicron variants in unimmunized infected (group 1), immunised and boosted (group 2) and infected immunised and boosted (group 3) adult i...

    Kevin K. Ariën, Leo Heyndrickx, Johan Michiels, Katleen Vereecken in npj Vaccines (2022)

  2. Article

    Open Access

    Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants

    Differences in innate immune ‘imprinting’ between vaccine adjuvants may mediate dissimilar effects on the quantity/quality of persisting adaptive responses. We compared antibody avidity maturation, antibody/me...

    Sonia Budroni, Francesca Buricchi, Andrea Cavallone, Patricia Bourguignon in npj Vaccines (2021)

  3. Article

    Open Access

    CD4+ T lymphocyte response to primary CMV infection

    Pierre Antoine, Véronique Olislagers, Sandra Lecomte, Corinne Liesnard in Retrovirology (2009)

  4. Article

    Open Access

    Mother and fetal immunity to cytomegalovirus

    Arnaud Marchant in Retrovirology (2009)